Resolving the tissue response to neoadjuvant chemotherapy in rectal cancer

Area of Science:

• Oncology
• Genomics
• Immunology

Background:

• Rectal cancer treatment often involves neoadjuvant chemotherapy.
• Understanding the tumor microenvironment (TME) is crucial for effective cancer therapy.
• Single-cell technologies offer high resolution for TME analysis.

Purpose of the Study:

• To comprehensively analyze the rectal cancer tumor microenvironment.
• To investigate the impact of neoadjuvant chemotherapy on the TME at a single-cell level.
• To identify cellular and molecular changes within the TME following treatment.

Main Methods:

• Single-cell RNA sequencing (scRNA-seq) was employed.
• Tumor samples were collected before and after neoadjuvant chemotherapy.
• Bioinformatic analyses were performed to characterize cell populations and states.

Main Results:

• Significant alterations in immune cell composition and function were observed post-chemotherapy.
• Specific cancer-associated fibroblast (CAF) subtypes showed dynamic changes.
• Identification of novel cellular interactions within the TME.

Conclusions:

• Neoadjuvant chemotherapy profoundly remodels the rectal cancer TME.
• These findings provide a detailed cellular map of treatment response.
• Insights may guide the development of novel therapeutic strategies for rectal cancer.